Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00923130
Title Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

renal cell carcinoma

kidney cancer


Bevacizumab + Ixabepilone

Age Groups: adult
Covered Countries USA

No variant requirements are available.